Univo Pharmaceuticals Ltd. Logo

Univo Pharmaceuticals Ltd.

Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.

UNVO-M | TA

Overview

Corporate Details

ISIN(s):
IL0010935588
LEI:
Country:
Israel
Address:
30 Haarbaa TEL AVIV-JAFFA, Central District, 6473926 Tel Aviv
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Univo Pharmaceuticals Ltd. is a vertically integrated biopharmaceutical company operating in the medical cannabis sector. The company manages the entire value chain, from research, development, and cultivation to the manufacturing and distribution of cannabis-based medical products. By maintaining full control over its processes, Univo aims to develop high-quality solutions to improve patient health and quality of life. The firm has a particular focus on developing treatments for the central nervous system (CNS) and operates a significant distribution network, supplying its products to numerous pharmacies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-08-10 19:49
Regulatory News Service
ISA informed TASE that the company is a "shell company", the company's securiti…
Hebrew (modern) 81.2 KB
2022-12-18 14:53
Regulatory News Service
Trading in the company's shares has been suspended as of today, on December 28…
Hebrew (modern) 80.0 KB
2022-12-12 11:07
Regulatory News Service
BOND SERIES A-TRADING SUSPENSION FOLLOWING TRUSTEE ANNOUNCEMENT REGARDING IMMED…
Hebrew (modern) 77.4 KB
2022-07-21 19:42
Regulatory News Service
Discontinuation of Market Making, If another market maker will not start to op…
Hebrew (modern) 255.5 KB

Automate Your Workflow. Get a real-time feed of all Univo Pharmaceuticals Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Univo Pharmaceuticals Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Univo Pharmaceuticals Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
SK Bioscience Co.,Ltd Logo
A global biotech firm developing vaccines for diseases like COVID-19, influenza, and shingles.
South Korea 302440
SoftOx Solutions AS Logo
Develops non-toxic, AMR-safe antimicrobials for wound care, disinfection & airway infections.
Norway SOFTX
Solasia Pharma K.K. Logo
In-licenses and commercializes oncology treatments and supportive care products in Asia.
Japan 4597
Sopharma AD Logo
Develops, manufactures, and distributes pharmaceuticals and generics in Bulgaria and regional markets.
Bulgaria SFA
Spago Nanomedical AB Logo
Developing nanomedicines for precise cancer diagnosis and targeted radionuclide therapy.
Sweden SPAGO
Spexis AG Logo
Clinical-stage biopharma developing macrocyclic therapeutics for rare diseases and oncology.
Switzerland SPEX
Sprint Bioscience Logo
Develops & out-licenses preclinical oncology drugs for difficult-to-treat cancers.
Sweden SPRINT
STADA Arzneimittel AG Logo
A leading European manufacturer of generics, consumer healthcare, and specialty pharmaceuticals.
Germany SAZ
Stayble Therapeutics AB Logo
Develops an injectable drug for lumbar disc herniation pain as an alternative to surgery.
Sweden STABL
STCUBE Logo
Develops first-in-class immunotherapies targeting BTN1A1 for treatment-resistant cancers.
South Korea 052020

Talk to a Data Expert

Have a question? We'll get back to you promptly.